Author: Maslow, Joel
Title: GeneOne Life Science Document date: 2018_10_26
ID: w7hf3kji_10
Snippet: GeneOne recently acquired GLS-1027, a small molecule that has been shown as active in multiple pre-clinical animal models of inflammatory and autoimmune diseases. GeneOne has also in-licensed from the University of Pennsylvania the use of quinine as a bitter taste receptor agonist for the treatment of sinus infection......
Document: GeneOne recently acquired GLS-1027, a small molecule that has been shown as active in multiple pre-clinical animal models of inflammatory and autoimmune diseases. GeneOne has also in-licensed from the University of Pennsylvania the use of quinine as a bitter taste receptor agonist for the treatment of sinus infection.
Search related documents:
Co phrase search for related documents- animal model and autoimmune inflammatory disease: 1
- animal model and receptor agonist: 1, 2, 3
- animal model and small molecule: 1, 2, 3, 4, 5
- autoimmune inflammatory disease and small molecule: 1, 2
- receptor agonist and small molecule: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date